News

OSHwiki article in the spotlight: Practical tips for a safe and healthy home-based telework

  • by

08/03/2021 OSHwiki article in the spotlight: Practical tips for a safe and healthy home-based telework Image by Vinzent Weinbeer from Pixabay The COVID-19 public health emergency prompted millions of European workers to work from home during the last year. Long periods of sedentary work, lack… Read More »OSHwiki article in the spotlight: Practical tips for a safe and healthy home-based telework

International Women’s Day 2021 – Taking action for equality at the workplace

  • by

08/03/2021 International Women’s Day 2021 – Taking action for equality at the workplace © Vector by freepik Every 8th of March continues raising awareness about the pending barriers and challenges in achieving gender equality for all. On International Women’s Day, at EU-OSHA we highlight how women,… Read More »International Women’s Day 2021 – Taking action for equality at the workplace

Home Health Giants Double Down on Diversion, as Nursing Home Numbers Normalize

  • by

Acute and post-acute patient volumes started to normalize in the early part of 2021, with hospitals, skilled nursing facilities (SNFs) and home health providers all hovering around their 2019 baselines. The accelerated rollout of COVID-19 vaccines is largely responsible for the newfound stability, particularly in… Read More »Home Health Giants Double Down on Diversion, as Nursing Home Numbers Normalize

74% of Referral Sources Prefer Home-Based Care Providers That Meet Interoperability Standards

  • by

When it comes to interoperability, 74% of referral sources say they would send more referrals to post-acute care providers — including home-based care agencies — that offer greater electronic data access.  In general, referral sources are more likely to switch to a home-based care provider… Read More »74% of Referral Sources Prefer Home-Based Care Providers That Meet Interoperability Standards

Therapy’s Future Under Patient-Driven Groupings Model Unclear Due to COVID-19 Chaos

  • by

The Patient-Driven Groupings Model (PDGM) was described as home health care’s “boogeyman” before it was implemented. One of the chief concerns, especially for therapists, was that therapy utilization would significantly decrease in 2020 — and beyond — because of what PDGM incentivizes.  But preliminary data… Read More »Therapy’s Future Under Patient-Driven Groupings Model Unclear Due to COVID-19 Chaos

One-size-fits-all addiction treatment must be replaced

  • by

While addiction treatment has traditionally focused on the removal of substance use ‘symptoms’ by collecting urine samples and screening for substance use, the complexity of the biopsychosocial framework requires commensurate measurement tooling.

 FDA OKs another over-the-counter Covid-19 test

  • by

As the Biden Administration pushes to offer more over-the-counter Covid-19 tests, the Food and Drug Administration authorized the first molecular Covid-19 test for over-the counter use. The test was developed by San Diego-based startup Cue Health.

Need to step up funding for health sector, bring equity in delivery of services: Harsh Vardhan

  • by

“A radical improvement in government facilities for the poor rather than only glitzy hospitals for the well-heeled along with the recent moves to lower prices of essential drugs and health equipment, are steps in the right direction,” a statement quoted the minister as saying at… Read More »Need to step up funding for health sector, bring equity in delivery of services: Harsh Vardhan

Kroger continues to support disaster response to uplift communities affected by Texas winter storm

  • by

Kroger continues to support disaster response to uplift communities affected by Texas winter storm Thu, 03/04/2021 – 19:00 cbaker_admin Sat, 03/06/2021 – 08:00 Kroger is distributing $270,000 in Helping Hands emergency grants to more than 500 associates in Texas affected by severe winter storms. The… Read More »Kroger continues to support disaster response to uplift communities affected by Texas winter storm

Effect of blinatumomab vs. chemotherapy on event-free survival among children with high-risk first-relapse B-ALL

  • by

Effect of blinatumomab vs. chemotherapy on event-free survival among children with high-risk first-relapse B-ALL Thu, 03/04/2021 – 19:00 cbaker_admin Sat, 03/06/2021 – 08:00 Researchers evaluated whether children with high-risk first-relapse B-cell acute lymphoblastic leukemia (B-ALL) benefit from blinatumomab as consolidation treatment prior to allogeneic hematopoietic… Read More »Effect of blinatumomab vs. chemotherapy on event-free survival among children with high-risk first-relapse B-ALL

Tired of reading glasses? Eye drop submitted for FDA approval may help you read without them

  • by

Tired of reading glasses? Eye drop submitted for FDA approval may help you read without them Thu, 03/04/2021 – 19:00 cbaker_admin Sat, 03/06/2021 – 08:00 AbbVie’s Allergan Eye Care division submitted an investigational eye drug for FDA approval that could potentially help more than 128… Read More »Tired of reading glasses? Eye drop submitted for FDA approval may help you read without them

Nivolumab plus cabozantinib vs. sunitinib for advanced renal-cell carcinoma

  • by

Nivolumab plus cabozantinib vs. sunitinib for advanced renal-cell carcinoma Thu, 03/04/2021 – 19:00 cbaker_admin Sat, 03/06/2021 – 08:00 The CheckMate 9ER study compared outcomes in patients with advanced renal-cell carcinoma after first-line treatment with either sunitinib or nivolumab plus cabozantinib. Researchers assembled a study population… Read More »Nivolumab plus cabozantinib vs. sunitinib for advanced renal-cell carcinoma

FDA is vigilant in protecting consumers against COVID-19 vaccine scams

  • by

FDA is vigilant in protecting consumers against COVID-19 vaccine scams Thu, 03/04/2021 – 19:00 cbaker_admin Sat, 03/06/2021 – 08:00 During National Consumer Protection Week, FDA wants to alert people to fraud and misleading claims related to COVID-19. Judy McMeekin, PharmD, FDA’s associate commissioner for regulatory… Read More »FDA is vigilant in protecting consumers against COVID-19 vaccine scams

Data Points: Another vaccination race for HPV

  • by

Roughly 1 in 4 Americans have human papillomavirus—HPV. While the infections often go away on their own, those that don’t are a leading cause of cancer, according to the Centers for Disease Control and Prevention.

Doctor appears in court video call while performing surgery

  • by

The judge said he didn’t think it was appropriate to conduct the trial under the circumstances. He told Green he’d rather set a new date for trial “when you’re not actively involved or participating and attending to the needs of a patient.”

bene : studio Launches HealthTech Product Accelerator Starting April 1st

  • by

What You Should Know: – bene : studio, a San Francisco, CA-based global digital product consultancy, announced its non-equity, online HealthTech Product Accelerator, starting on April 1st. The accelerator will focus exclusively on the enhancement of the participating companies’ design and technology. – This accelerator… Read More »bene : studio Launches HealthTech Product Accelerator Starting April 1st

Shares of insurer Oscar Health fall following $1.4B IPO

  • by

Oscar Health’s share price on the New York Stock Exchange hovered around $31 Friday afternoon before market close, a decline of about 20% from the $39 pricing the company set for its initial public offering Tuesday evening. 

Public Notification: Alpha Male Plus contains hidden drug ingredient

  • by

The Food and Drug Administration is advising consumers not to purchase or use Alpha Male Plus (also referred to as Alpha Male+), a product promoted and sold for sexual enhancement on various websites, including https://alphamaleplus.us, and possibly in some retail stores.

FDA signals plan to address toxic elements in baby food

  • by

The Food and Drug Administration (FDA) on Friday signaled that it intends to address toxic elements in baby foods after a congressional report found that heavy metals were present in some baby foods. The agency said in a statement that it will “soon…

Next Up Podcast: What’s going to happen tomorrow? Succession planning during emergencies

  • by

Before the pandemic, a majority of U.S. healthcare industry leaders—including nearly half of the nation’s hospital boards—said their organization did not have a formal succession plan in place. Modern Healthcare’s “Next Up” podcast is produced by CareContent, Inc. and hosted by CareContent’s CEO, Kadesha Thomas… Read More »Next Up Podcast: What’s going to happen tomorrow? Succession planning during emergencies

BioIntelliSense Partners with Leukemia & Lymphoma Society for Continuous Monitoring in Clinical Trials

  • by

What You Should Know: –BioIntelliSense announced it has entered into a strategic partnership with The Leukemia & Lymphoma Society (LLS) to incorporate the BioSticker™ platform in clinical trials of hematological cancer patients. – The LLS clinical trials will include use of the BioSticker medical device… Read More »BioIntelliSense Partners with Leukemia & Lymphoma Society for Continuous Monitoring in Clinical Trials

Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease

  • by

Jon Gingrich, CEO, Echosens North America Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program not only serves to improve individual outcomes and reduce costs but also strengthens the financial performance of health systems and… Read More »Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease

Detroit mayor declines Johnson & Johnson vaccine shipment

  • by

Detroit Mayor Mike Duggan (D) is defending his decision to reject a shipment of the Johnson & Johnson vaccine, saying in a press conference Thursday that the Pfizer and Moderna vaccines are better and he wants Detroit residents to “get the best…

New method facilitates development of antibody-based drugs

  • by

In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers have developed a new, efficient method based on the genetic scissors CRISPR-Cas9, that facilitates antibody development.

Antibiotic-resistant strains of staph bacteria may be spreading between pigs raised in factory farms

  • by

DNA sequencing of bacteria found in pigs and humans in rural eastern North Carolina, an area with concentrated industrial-scale pig-farming, suggests that multidrug-resistant Staphylococcus aureus strains are spreading between pigs, farmworkers, their families and community residents, and represents an emerging public health threat, according to… Read More »Antibiotic-resistant strains of staph bacteria may be spreading between pigs raised in factory farms

CDC study links masks to fewer COVID deaths

  • by

A new study from the Centers for Disease Control and Prevention finds that mask mandates were linked to a decline in COVID-19 cases and deaths. The study also found that allowing restaurant dining was linked to increases in cases and deaths.&…

Johnson & Johnson vaccine approved in Canada

  • by

Canadian health officials on Friday announced the approval of Johnson & Johnson’s COVID-19 vaccine.At a media briefing in Ottawa, government officials said they have ordered 10 million doses, with the option to purchase 28 million more…

Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive

  • by

Last week, PhRMA submitted comments to the United States Patent and Trademark Office (USPTO) in response to a request for comments on the National Strategy for Expanding American Innovation. PhRMA’s comments focus on the types of initiatives and efforts that could be included in a… Read More »Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive

Hairdressing social partners bring better OSH protection to workers across Europe

  • by

Back to news 05/03/2021 Hairdressing social partners bring better OSH protection to workers across Europe Representatives of European social partners in the hairdressing sector and EU-OSHA’s Healthy Workplaces official campaign partners UNI Europa and Coiffure EU, continue their commitment to promoting sustainable working conditions in… Read More »Hairdressing social partners bring better OSH protection to workers across Europe

New way to halt excessive inflammation

  • by

Researchers have discovered a new way to ‘put the brakes’ on excessive inflammation by regulating a type of white blood cell that is critical for our immune system.

Eli Lilly and Incyte Report Results of Olumiant (baricitinib) in P-III BRAVE-AA2 Study for Severe Alopecia Areata

  • by

Shots: The P-III BRAVE-AA2 study involves assessing Baricitinib (2mg & 4mg, qd) vs PBO in 546 adults with a SALT score ≥ 50 (i.e., who had ≥50% scalp hair loss) and a current episode of severe AA lasting at least 6mos. but no >8yrs. The… Read More »Eli Lilly and Incyte Report Results of Olumiant (baricitinib) in P-III BRAVE-AA2 Study for Severe Alopecia Areata

Virginia pharmacies will now book COVID-19 vaccine appointments via statewide system

  • by

Virginia pharmacies will now book COVID-19 vaccine appointments via statewide system Wed, 03/03/2021 – 19:00 cbaker_admin Fri, 03/05/2021 – 07:30 Pharmacies in Virginia will now be aligning with the state’s COVID-19 vaccine rollout, which prioritizes older adults. Danny Avula, MD, Virginia’s state vaccine coordinator, notes… Read More »Virginia pharmacies will now book COVID-19 vaccine appointments via statewide system

More than 200,000 Americans sign up for ACA health plans during special enrollment period

  • by

More than 200,000 Americans sign up for ACA health plans during special enrollment period Wed, 03/03/2021 – 19:00 cbaker_admin Fri, 03/05/2021 – 07:30 Data released Wednesday by federal health officials revealed that a total of 206,236 Americans signed up for Affordable Care Act health plans… Read More »More than 200,000 Americans sign up for ACA health plans during special enrollment period

Effect of postreinduction therapy consolidation with blinatumomab vs. chemotherapy in children, adolescents, and young adults with first relapse of B-cell ALL

  • by

Effect of postreinduction therapy consolidation with blinatumomab vs. chemotherapy in children, adolescents, and young adults with first relapse of B-cell ALL Wed, 03/03/2021 – 19:00 cbaker_admin Fri, 03/05/2021 – 07:30 Researchers explored whether postreinduction treatment with blinatumomab, rather than with chemotherapy, might generate more favorable… Read More »Effect of postreinduction therapy consolidation with blinatumomab vs. chemotherapy in children, adolescents, and young adults with first relapse of B-cell ALL

Novel biobattery-powered microneedle patch enables delivery of large molecule drugs

  • by

Researchers at Tohoku University have developed a biobattery-powered device capable of both delivering large molecule pharmaceuticals across the skin barrier and extracting interstitial fluid for diagnostic purposes. According to its developers, the organic drug delivery patch, which they are now working to make biodegradable could… Read More »Novel biobattery-powered microneedle patch enables delivery of large molecule drugs

Friday Links

  • by

Food insecurity and health care spending. Access in a new world. Credibility Revolutionistas.  Do individuals with limited English proficiency use telehealth? Desk clearing and drug safety. UCI: Re-open California schools

US closes enrolment in two COVID-19 antibody studies due to futility

  • by

The US National Institutes of Health (NIH) has closed enrolment of two sub-studies in the ACTIV-3 trial evaluating monoclonal antibody therapies in adult patients hospitalised with COVID-19. The studies evaluating GlaxoSmithKline and Vir Biotechnology’s VIR-7831 and Brii Biosciences’ combination of BRII-196 and BRII-198 were both… Read More »US closes enrolment in two COVID-19 antibody studies due to futility

Biden faces criticism over push to vaccinate teachers

  • by

The Biden administration is defending the president’s decision to prioritize vaccinations for teachers and school staff.Critics charge it will deepen inequalities around vaccine access and allege President Biden is bowing to pressure from teachers…

Roche’s Actemra/RoActemra (tocilizumab) Receives the US FDA’s Approval as the First Biologic for Systemic Sclerosis-Associated Interstitial Lung Disease

  • by

Shots: The approval is based on P-III focuSSced trial assessing Actemra (SC, 162mg) vs PBO in a ratio (1:1) in 212 adults with SSc. The data from P-I/II fascinate study also supported the approval The P-III study did not meet its 1EPs i.e. change from… Read More »Roche’s Actemra/RoActemra (tocilizumab) Receives the US FDA’s Approval as the First Biologic for Systemic Sclerosis-Associated Interstitial Lung Disease

Lilly Reports Results of Tirzepatide in P-lll SURPASS-2 Trial for Type-2 Diabetes

  • by

Shots: The P-III SURPASS-2 trial involves assessing Tirzepatide (5/10/15mg) vs Semaglutide (1mg) in 1,879 patients in a ratio (1:1:1:1) with T2D inadequately controlled with ≥1500 mg/day metformin alone for 40wks. Results: A1C reduction: (-2.09% /-2.37%/-2.46% vs- 1.86%); Weight reduction: (-7.8/-10.3/-12.4kg vs -6.2 kg); patients achieving… Read More »Lilly Reports Results of Tirzepatide in P-lll SURPASS-2 Trial for Type-2 Diabetes

US picks up vaccination pace, averaging 2M doses per day

  • by

The United States is administering an average of 2 million doses of COVID-19 vaccines per day, according to an analysis from The New York Times. The average is up from one month ago, when the daily average was about 1.3 million doses, according to…

‘We’re a Strong Alternative to Nursing Homes’: PACE Giant InnovAge Executes $350M IPO

  • by

InnovAge (Nasdaq: INNV), a Program of All-Inclusive Care for Elderly (PACE) provider, officially went public Thursday. Denver-based InnovAge offers one of the largest PACE programs in the U.S. The company has about 1,900 employees and serves 6,600 seniors in Colorado, New Mexico, California, Pennsylvania and… Read More »‘We’re a Strong Alternative to Nursing Homes’: PACE Giant InnovAge Executes $350M IPO

Florida governor faces growing charges of vaccine favoritism

  • by

Florida Gov. Ron DeSantis pushed back on allegations that wealthy Floridians are getting earlier access to coronavirus vaccines, saying a local hospital—not the state—was behind the vaccinations of more than 1,200 Key Largo residents.